I am pleased to congratulate the Journal of Spine Surgery on achieving its first Impact Factor. This is an important milestone and a meaningful recognition of the work carried out by the editorial team, reviewers, authors, and contributors over the years.

In a field such as spine surgery, where clinical practice, technology, biomechanics, and outcomes research continue to evolve rapidly, JSS has built an important role as an international platform for rigorous and clinically relevant academic discussion.

As an Editorial Board Member, I am honored to contribute to the journal’s development and I look forward to seeing JSS further strengthen its scientific impact and international visibility.

It is encouraging to see VATS receive its latest impact factor and CiteScore. These are welcome milestones, but the journal’s main value remains its focus on clinically relevant work in minimally invasive thoracic surgery.

As Editor-in-Chief, I hope VATS will keep attracting thoughtful submissions and publishing work that is useful to surgeons in daily practice. I am grateful to everyone who has contributed to the journal so far, and I look forward to seeing it continue to grow.

I've enjoyed being part of VATS's editorial board and seeing how the journal has evolved. Going forward, I'd like to see more submissions from surgical teams outside the usual high-volume centers; that's often where the most honest data on real-world outcomes comes from. Congratulations on the progress so far.

Pediatric Medicine has received its first impact factor. This represents a milestone in the journal’s development. The mission of PM is to bring pediatricians, at the intersection of clinical practice and translational research, to ultimately improve health care delivery and promote children’s health. The new impact factor demonstrates that this ambitious goal is within reach.

As Editor-in-Chief of the journal Neonatology, I am a close observer of the rise of Chinese neonatology. In my opinion there is a need for a Chinese based journal of Pediatrics, as Pediatric Medicine, in order to absorb the rapid growth in high quality scientific manuscripts coming from PRC. When combining this with an international perspective the future of PM is bright.

Every Innovation Begins with a Single Patient

I am honored to congratulate the Editorial Board, reviewers, authors, and the entire AME Publishing team on the achievement of an official Impact Factor for AME Case Reports. This important milestone reflects the journal's unwavering commitment to scientific quality, educational value, and international collaboration.

Throughout my career as a cardiovascular surgeon, I have treated many patients with complex aortic diseases, valvular heart disorders, and high-risk conditions, including transfusion-free cardiac surgery. These experiences have continually reinforced one important belief: every medical innovation begins with a single patient. Before new concepts are incorporated into guidelines or supported by large clinical trials, they often originate from carefully observed and thoughtfully reported individual cases.

For this reason, I consider case reports not as the lowest level of evidence, but as the foundation of clinical innovation. They preserve invaluable experiences, encourage critical thinking, generate new hypotheses, and provide practical lessons that may benefit patients around the world. Particularly in cardiovascular surgery, where each operation presents unique anatomical and technical challenges, sharing these experiences is essential for advancing our field.

AME Case Reports has created an outstanding international platform where clinicians can exchange meaningful experiences with scientific rigor and educational purpose. The journal has successfully connected physicians across specialties and countries, fostering collaboration and continuous learning. The newly awarded Impact Factor is a well-deserved recognition of these efforts.

Looking ahead, I hope the journal will continue to encourage reports of innovative surgical techniques, multidisciplinary decision-making, ethical challenges, and long-term clinical outcomes. Such contributions will not only strengthen the journal's academic influence but also inspire the next generation of clinicians and surgeon-scientists.

It has been a privilege to contribute to AME Case Reports, and I look forward to witnessing its continued growth as one of the leading international journals dedicated to high-quality clinical case reports.

I would like to congratulate the all team of the AME Case Reports (ACR) for the new impact factor. As a urologist, I observe that ACR has improved the quality of the published clinical cases more and more. I am glad to be able to participate in this journey. Go ahead!